← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Century Therapeutics IPSC $264M	36	+36	–	$491M
77	77 Opus Genetics IRD $341M	36	+9	+33%	$5.61M
78	ONCS 78 DELISTED OncoSec Medical Incorporated ONCS	35	+1	+3%	$19.2M
79	79 Celularity CELU $42.2M	33	-30	-48%	$93.8M
80	80 DELISTED Orgenesis Inc. Common Stock ORGS	33	-6	-15%	$11.1M
81	81 Eterna Therapeutics ERNA $2.47M	32	+25	+357%	$78.7M
82	82 Genprex GNPX $1.96M	32	-6	-16%	$19.5M
83	GRCL 83 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	32	-4	-11%	$270M
84	84 Capricor Therapeutics CAPR $401M	31	+1	+3%	$18.1M
85	BLCM 85 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	30	+1	+3%	$5.13M
86	ACHL 86 DELISTED Achilles Therapeutics ACHL	29	0	0%	$184M
87	87 DELISTED Scorpius Holdings, Inc. SCPX	28	-4	-13%	$17.9M
88	RCOR 88 DELISTED Renovacor, Inc. RCOR	25	+3	+14%	$56.9M
89	89 BioCardia BCDA $14.4M	20	+1	+5%	$12.3M
90	90 Enlivex Ltd ENLV $4.39M	20	-3	-13%	$8.79M
91	91 Benitec Biopharma BNTC $300M	16	+2	+14%	$6.46M
92	FRLN 92 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	16	-3	-16%	$91.6M
93	KRBP 93 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	15	+4	+36%	$11.9M
94	SCPS 94 DELISTED Scopus BioPharma Inc. Common Stock SCPS	15	-13	-46%	$1.07M
95	LGVN 95 Longeveron LGVN $5.1M	11	+2	+22%	$2.96M
96	CYAD 96 DELISTED Celyad Oncology SA American Depositary Shares CYAD	7	+1	+17%	$1.49M
97	97 NewcelX Ltd NCEL $15.3M	4	+1	+33%	$205K
98	98 DELISTED Arcellx ACLX	–	–	–	–
99	99 Artiva Biotherapeutics ARTV $299M	–	–	–	–
100	100 BioRestorative Therapies BRTX $1.98M	–	–	–	–